Regional Cancer Care Associates (RCCA), New Jersey's largest oncology
physician network, is pleased to announce the appointment of Andre Goy,
M.D., M.S. as Chief Science Officer and Director of Research and
Innovation. Dr. Goy will continue to serve as Chairman and Executive
Director at John Theurer Cancer Center at HackensackUMC, one of the 50
best hospitals for cancer and RCCA's Hackensack location. In this new
role, Dr. Goy will bring cutting-edge research and clinical trials to
RCCA locations, giving patients access to novel therapies in local
communities across New Jersey.
Dr. Andre Goy appointed as Chief Science Officer and Director of Research and Innovation of Regional Cancer Care Associates (Photo: Business Wire)
"Dr. Goy has been instrumental in elevating John Theurer Cancer Center's
research program to become one of the largest, most active in the
nation," said Andrew L. Pecora, M.D., F.A.C.P., C.P.E., President of
RCCA. "Under Dr. Goy's leadership, patients throughout New Jersey will
have the opportunity to access cutting-edge clinical trials and, in
turn, John Theurer Cancer Center's nationally-recognized research
progrm will be able to provide greater contributions to cancer
Dr. Goy will be responsible for developing strategies that will
integrate research throughout the RCCA network, which includes 92 cancer
care specialists at 25 care delivery sites, providing care to more than
230,000 patients. He will focus on novel therapies and biomarker-driven
research, a targeted approach to determining how likely a patient may
respond to a specific treatment.
"Clinical trials allow us to give patients early-access to possible
life-saving treatments," said Dr. Goy. "Our goal is to ensure that
clinical trials are always considered in every step of the treatment
decision and that clinical trial participation is made available to our
patients closer to their home."
Dr. Goy is an internationally renowned clinician and researcher. Since
joining John Theurer Cancer Center, Dr. Goy has spearheaded the
development of its Tissue Bank and led New Jersey's largest program for
lymphoma. He has supported the growth of the research program, which now
includes more than 200 clinical trials across 14 cancer divisions and
includes Phase I, II and III protocols. Dr. Goy has trained at the
world's leading medical institutions, including Memorial Sloan-Kettering
Cancer Center, M.D. Anderson Cancer Center, Assistance Publique in Paris
(the largest university hospital system in Europe) and The Pasteur
Institute, also in Paris.
"Dr. Goy has a proven track-record of successfully leading global
research studies that have helped bring life-saving therapies to
patients," said Edward J. Licitra, M.D., Ph.D., Board Chairman, RCCA.
"We are pleased to bring his expertise to RCCA for the benefit of our
About Regional Cancer Care Associates
Regional Cancer Care Associates (RCCA), the largest oncology physician
network in New Jersey, is transforming oncology care by ensuring
patients and their caregivers are an active part of the treatment team
in all aspects of the management of their disease in a way that is
life-enriching and respectful.
Regional Cancer Care Associates extends across New Jersey with more than
90 cancer care specialists, growing to include more than 100, and is
supported by 600 employees at 25 care delivery sites, providing care to
more than 20,000 new patients annually and over 230,000 existing
patients. For more information, visit www.RC2ACancerCare.com.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20130123006287/en/
[ Back To NFVZone's Homepage ]